miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy

Abstract Background Accumulating evidence has revealed that aberrant microRNA (miRNA) expression can affect the development of chemotherapy drug resistance by modulating the expression of relevant target proteins. Emerging evidence has demonstrated that miR-133a participates in the tumorigenesis of...

Full description

Bibliographic Details
Main Authors: Yang Zhou, Chunyan Wang, Jinye Ding, Yingying Chen, Yaoqi Sun, Zhongping Cheng
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Cancer Cell International
Subjects:
miR-133a
Ovarian cancer
YES1
Cisplatin resistance
Autophagy
Online Access:https://doi.org/10.1186/s12935-021-02412-x

Internet

https://doi.org/10.1186/s12935-021-02412-x

Similar Items